CTU: AN INTERVENTIONAL, DOUBLE-BLIND, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS FULVESTRANT COMPARED TO FULVESTRANT IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR CDK 4/6 INHIBITOR BASED THERAPY

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleC4391022
StatusActive
Effective start/end date27/02/2427/02/29